S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in
NASDAQ:MRNS

Marinus Pharmaceuticals Earnings Date, Estimates & History

$13.51
+0.31 (+2.35 %)
(As of 01/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$12.86
Now: $13.51
$13.66
50-Day Range
$11.81
MA: $12.84
$15.61
52-Week Range
$4.16
Now: $13.51
$17.14
Volume272,672 shs
Average Volume378,634 shs
Market Capitalization$413.32 million
P/E RatioN/A
Dividend YieldN/A
Beta1.72

Earnings

Marinus Pharmaceuticals (NASDAQ:MRNS) Earnings Information

Marinus Pharmaceuticals last released its quarterly earnings results on November 9th, 2020. The biopharmaceutical company reported ($0.51) EPS for the quarter, topping analysts' consensus estimates of ($0.60) by $0.09. Marinus Pharmaceuticals has generated ($3.96) earnings per share over the last year. Marinus Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 15th, 2021 based off prior year's report dates.

Marinus Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Marinus Pharmaceuticals (NASDAQ:MRNS) Earnings Estimates

2021 EPS Consensus Estimate: ($1.77)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20212($0.50)($0.48)($0.49)
Q2 20212($0.42)($0.41)($0.42)
Q3 20212($0.43)($0.42)($0.43)
Q4 20212($0.46)($0.42)($0.44)

Marinus Pharmaceuticals (NASDAQ MRNS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/15/2021
(Estimated)
       
11/9/20209/30/2020($0.60)($0.51)($0.51)Transcript
8/6/20206/30/2020($0.76)($0.64)($0.16)N/A
5/4/20203/31/2020($0.64)($1.28)($0.32)Transcript
3/16/202012/31/2019($0.84)($1.00)($0.26)N/A
11/6/2019Q3($0.9480)($1.04)($0.26)N/A
8/8/2019Q2 2019($0.9360)($0.96)($0.24)N/A
5/1/2019Q1 2019($0.8480)($0.96)($0.24)N/A
3/11/201912/31/2018($1.04)($0.96)($0.24)N/A
10/29/20189/30/2018($0.84)($1.08)($0.27)N/A
8/2/2018Q2 2018($0.60)($0.96)($0.24)N/A
5/2/2018Q1 2018($0.64)($0.60)($0.15)N/A
3/6/2018Q4 2017($0.52)($0.80)($0.20)N/A
10/31/2017Q3 2017($0.68)($0.60)($0.15)N/A
8/1/2017Q2 2017($1.08)($0.84)($0.21)N/A
5/1/2017Q1 2017($1.28)($1.04)($0.26)N/A
3/13/2017Q4 2016($1.32)($1.24)($0.31)N/A
11/3/2016Q3($1.72)($1.32)($0.33)N/A
8/9/2016Q2($1.52)($1.84)($0.46)N/A
5/2/2016Q1 2016($1.64)($1.48)($0.37)N/A
3/7/2016Q416($1.52)($1.80)($0.45)N/A
10/29/2015Q3 2015($2.04)($1.40)($0.35)N/A
8/4/2015Q2 2015($2.04)($1.48)($0.37)N/A
5/11/2015Q1 2015($1.88)($2.00)($0.50)N/A
3/12/2015Q4 2014($1.04)($0.26)N/A
11/13/2014Q3 14($2.00)($1.20)($0.38)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 1/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.